Abstract: The present invention provides chemokine receptor antibodies that selectively bind to an activated form of the receptor but not to a non activated form of the receptor. In particular, the current invention provides phospho specific chemokine receptor antibodies. The antibodies can be used in several diagnostic, screening and purification methods.
Type:
Application
Filed:
June 30, 2006
Publication date:
July 2, 2009
Applicant:
National Institutes of Health (NIH), U.S. Dept. of Health and Human Services (DHHS), U.S. Gov.